<?xml version='1.0' encoding='utf-8'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>PACVS clinical trials: new and updated - Open Source Medicine Foundation</title><link>https://research.opensourcemed.info/pacvs.html</link><description>ClinicalTrials.gov records for Post-Acute COVID-19 Vaccination Syndrome (PACVS) that were newly registered or updated, as tracked by the Open Source Medicine Foundation research tracker. The 30 most recently updated trials, newest first.</description><language>en</language><lastBuildDate>Fri, 09 Oct 2026 11:21:14 +0000</lastBuildDate><generator>OSMF build_condition_feeds.py</generator><ttl>1440</ttl><atom:link href="https://research.opensourcemed.info/feeds/pacvs.xml" rel="self" type="application/rss+xml" /><image><url>https://opensourcemed.info/favicon.png</url><title>PACVS clinical trials: new and updated - Open Source Medicine Foundation</title><link>https://research.opensourcemed.info/pacvs.html</link></image><item><title>DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury</title><link>https://clinicaltrials.gov/study/NCT07567274</link><guid isPermaLink="false">NCT07567274:2026-05-13</guid><pubDate>Wed, 13 May 2026 08:00:00 +0000</pubDate><category>PACVS</category><category>Enrolling By Invitation</category><description>Enrolling By Invitation · Phase 2 · Dmso-Based Otic Solution With Betahistine, Dexamethasone, And Lidocaine, N-Acetylcysteine (NAC) — The goal of this clinical trial is to test a compounded dimethyl sulfoxide (DMSO)-based dual-route therapy for adults with refractory subjective tinnitus linked to long-COVID (post-acute sequelae of SARS-CoV-2) or post-COVID-19 vaccine injury. Participants have bothersome tinnitus that has not impro…</description></item></channel></rss>